Cover Image
市場調查報告書

Laboratorios Sophia S.A. de C.V. - 產品平台分析

Laboratorios Sophia S.A. de C.V. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 310063
出版日期 內容資訊 英文 20 Pages
訂單完成後即時交付
價格
Back to Top
Laboratorios Sophia S.A. de C.V. - 產品平台分析 Laboratorios Sophia S.A. de C.V. - Product Pipeline Review - 2015
出版日期: 2015年06月24日 內容資訊: 英文 20 Pages
簡介

Laboratorios Sophia S.A. de C.V.正在開發並商品化眼科醫及其患者用眼科產品。涵蓋產品有點眼藥,分別由二個品牌推出其產品。

本報告提供Laboratorios Sophia S.A. de C.V.的治療藥開發平台現狀及各開發階段比較分析,彙整藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Laboratorios Sophia S.A. de C.V.的基本資料

Laboratorios Sophia S.A. de C.V.概要

  • 主要資訊
  • 企業資料

Laboratorios Sophia S.A. de C.V.:R&D概要

  • 主要的治療範圍

Laboratorios Sophia S.A. de C.V.:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Laboratorios Sophia S.A. de C.V.:開發中產品概況

  • 最後階段的開發中產品
    • 第三階段的產品/聯合治療模式
  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式

Laboratorios Sophia S.A. de C.V.:藥物簡介

  • PRO-148
  • PRO-155
  • PRO-156
  • 各給藥途徑產品平台
  • 各分子類型產品平台

Laboratorios Sophia S.A. de C.V.:暫停中的計劃

Laboratorios Sophia S.A. de C.V.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07162CDB

Summary

Global Markets Direct's, 'Laboratorios Sophia S.A. de C.V. - Product Pipeline Review - 2015', provides an overview of the Laboratorios Sophia S.A. de C.V.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Laboratorios Sophia S.A. de C.V.'s, com-lete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Laboratorios Sophia S.A. de C.V. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Laboratorios Sophia S.A. de C.V.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Laboratorios Sophia S.A. de C.V.'s pipeline products

Reasons to buy

  • Evaluate Laboratorios Sophia S.A. de C.V.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Laboratorios Sophia S.A. de C.V. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Laboratorios Sophia S.A. de C.V.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Laboratorios Sophia S.A. de C.V. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Laboratorios Sophia S.A. de C.V.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Laboratorios Sophia S.A. de C.V. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Laboratorios Sophia S.A. de C.V. Snapshot
    • Laboratorios Sophia S.A. de C.V. Overview
    • Key Information
    • Key Facts
  • Laboratorios Sophia S.A. de C.V. - Research and Development Overview
    • Key Therapeutic Areas
  • Laboratorios Sophia S.A. de C.V. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Laboratorios Sophia S.A. de C.V. - Pipeline Products Glance
    • Laboratorios Sophia S.A. de C.V. - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • Laboratorios Sophia S.A. de C.V. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
  • Laboratorios Sophia S.A. de C.V. - Drug Profiles
    • PRO-148
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PRO-155
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PRO-156
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Laboratorios Sophia S.A. de C.V. - Pipeline Analysis
  • Laboratorios Sophia S.A. de C.V. - Pipeline Products by Route of Administration
  • Laboratorios Sophia S.A. de C.V. - Pipeline Products by Molecule Type
  • Laboratorios Sophia S.A. de C.V. - Dormant Projects
  • Laboratorios Sophia S.A. de C.V. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Laboratorios Sophia S.A. de C.V., Key Information
  • Laboratorios Sophia S.A. de C.V., Key Facts
  • Laboratorios Sophia S.A. de C.V. - Pipeline by Indication, 2015
  • Laboratorios Sophia S.A. de C.V. - Pipeline by Stage of Development, 2015
  • Laboratorios Sophia S.A. de C.V. - Monotherapy Products in Pipeline, 2015
  • Laboratorios Sophia S.A. de C.V. - Phase III, 2015
  • Laboratorios Sophia S.A. de C.V. - Phase II, 2015
  • Laboratorios Sophia S.A. de C.V. - Phase I, 2015
  • Laboratorios Sophia S.A. de C.V. - Pipeline by Route of Administration, 2015
  • Laboratorios Sophia S.A. de C.V. - Pipeline by Molecule Type, 2015
  • Laboratorios Sophia S.A. de C.V. - Dormant Developmental Projects,2015
  • Laboratorios Sophia S.A. de C.V., Other Locations

List of Figures

  • Laboratorios Sophia S.A. de C.V. - Pipeline by Top 10 Indication, 2015
  • Laboratorios Sophia S.A. de C.V. - Pipeline by Stage of Development, 2015
  • Laboratorios Sophia S.A. de C.V. - Monotherapy Products in Pipeline, 2015
  • Laboratorios Sophia S.A. de C.V. - Pipeline by Top 10 Route of Administration, 2015
Back to Top